OR WAIT null SECS
March 07, 2022
Researchers at McGill University have made advancements with a novel method for growing synthetic bone tissue.
Bio-Rad has launched a range of antibodies specifically for daratumumab that inhibit the binding of the drug to the target antigen, CD38, which allows for highly specific bioanalysis and drug monitoring.
March 04, 2022
FDA’s CDER continues to make rare diseases a priority with drug approvals and programming to speed therapeutic development.
The Luna Probe One-Step RT-qPCR Mix with UDG is designed to enable sensitive, linear, real-time detection of target RNA sequences.
Genoox will use their genomic data platform to validate Element's AVITI system.
EMA’s PRIME scheme has enabled life-changing medicines to become available to patients at a faster rate.
MHRA has awarded Promising Innovation Medicine (PIM) designation to rezafungin for the treatment of invasive candidiasis.
Evonik has increased its global supply of plant-derived cholesterol used for mRNA vaccines and gene therapies.
March 03, 2022
A consortium of nine development partners will support Biovac's expansion of its existing vaccine manufacturing plant capacity, while Biovac itself aims to raise funds to boost increased vaccine manufacturing capacity across Africa.
Aceto has acquired Biotron Laboratories and Talus Mineral Company.